entertainment -WSS

entertainment

author：hotspot 2025-09-27 23:02:23 - browse：14

A judge ruled that Welsh Carson won't have to face antitrust allegations about its anesthesiology practice. Adobe

Welsh, Carson, Anderson & Stowe has wiggled out of the grasp of the Federal Trade Commission, but the private equity firm’s anesthesia company, U.S. Anesthesia Partners, still must face the agency’s antitrust case, a judge ruled last week.

The FTC alleged last year that the anesthesiology network monopolized markets in Texas to drive up prices, but took the unusual step of attaching Welsh Carson as a defendant with USAP. Dismissing Welsh Carson from the case was a victory for the private equity firm and, more broadly, other firms worried that the Biden administration would try to hold them responsible for anything their portfolio companies do.

But the allegations against USAP didn’t disappear, which will keep up scrutiny on companies that have made a push to acquire numerous physician groups.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： AI used to predict Covid

Wikipedia

WSS

Why you get paid to donate plasma but not blood

Health insurers say they are turning to AI to cut costs, improve care

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Focused ultrasound for uterine fibroids: an uphill battle

Startling documents reveal new facets of Sacklers' opioid empire

Do more moles mean more problems? Not so, says new study

hotspot

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Medicare proposal to cover medical devices draws a mixed reaction

Flagship, Pfizer team up in deal worth up to $7 billion

How to save PrEP access — and even expand it

A look at other Americans who have crossed into North Korea over the years

Medicare proposal to cover medical devices draws a mixed reaction

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Walensky prepares to leave CDC — and Congress — behind

15 die by electrocution after transformer explodes in northern India

focus

Addiction doctors spar with methadone clinics over legislation

David Sabatini, ex

FDA seeking to stop procedures at two unregulated stem cell clinics

Twill hunts for pharma partner to market its depression app

Adam's Biotech Scorecard: Do Sarepta's exon

What we know about the American soldier detained in North Korea

Wikipedia

knowledge

focus

entertainment